Annual Drug Patent Expirations for ZOLINZA
Zolinza is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
This drug has one hundred and twenty-seven patent family members in thirty-five countries.
The generic ingredient in ZOLINZA is vorinostat. One supplier is listed for this compound. Additional details are available on the vorinostat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com